Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Aminolevulinic acid
Drug ID BADD_D00110
Description A compound produced from succinyl-CoA and glycine as an intermediate in heme synthesis. It is used as a photochemotherapy for actinic keratosis. [PubChem]
Indications and Usage Aminolevulinic acid plus blue light illumination using a blue light photodynamic therapy illuminator is indicated for the treatment of minimally to moderately thick actinic keratoses of the face or scalp.
Marketing Status Prescription
ATC Code L01XD04
DrugBank ID DB00855
KEGG ID D07567
MeSH ID D000622
PubChem ID 137
TTD Drug ID D0Y7ZD
NDC Product Code 46016-5450
Synonyms Aminolevulinic Acid | Acid, Aminolevulinic | Delta-Aminolevulinic Acid | Acid, Delta-Aminolevulinic | Delta Aminolevulinic Acid | Levulan | 5-Aminolaevulinate | 5 Aminolaevulinate | 5-Aminolevulinate | 5 Aminolevulinate | Aminolevulinic Acid Hydrochloride | Acid Hydrochloride, Aminolevulinic | Hydrochloride, Aminolevulinic Acid
Chemical Information
Molecular Formula C5H9NO3
CAS Registry Number 106-60-5
SMILES C(CC(=O)O)C(=O)CN
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Acne23.02.01.001--Not Available
Alanine aminotransferase increased13.03.01.003--
Amnesia19.20.01.001; 17.03.02.0010.000533%
Amylase increased13.05.01.009--
Anaemia01.03.02.001--
Aphasia19.21.01.001; 17.02.03.001--
Application site irritation12.07.01.003; 08.02.01.003--Not Available
Application site reaction12.07.01.006; 08.02.01.006--Not Available
Aspartate aminotransferase increased13.03.01.006--
Basal cell carcinoma23.08.02.001; 16.03.02.0010.000533%Not Available
Blood bilirubin increased13.03.01.008--
Body temperature increased13.15.01.001--Not Available
Chills15.05.03.016; 08.01.09.001--
Dermatitis23.03.04.002--Not Available
Diarrhoea07.02.01.001--
Discomfort08.01.08.003--Not Available
Dry skin23.03.03.001--
Dysaesthesia17.02.06.003--
Embolism venous24.01.01.003--Not Available
Erythema23.03.06.0010.001066%Not Available
Eye disorder06.08.03.001--Not Available
Eye irritation06.04.05.0030.000799%Not Available
Eyelid oedema23.04.01.003; 10.01.05.001; 06.04.04.004--Not Available
Feeling hot08.01.09.009--Not Available
Gamma-glutamyltransferase increased13.03.01.011--
Gastrointestinal disorder07.11.01.001--Not Available
Glioma16.30.01.004; 17.20.01.004--Not Available
Haemoglobin13.01.05.018--Not Available
Headache17.14.01.001--
Hemianopia17.17.01.012; 06.02.07.004--Not Available
The 1th Page    1 2 3 4    Next   Last    Total 4 Pages